China Top 10 Rabies Vaccine Oral Potential Enterprises

April 05, 2024

The rabies vaccine oral market is experiencing steady growth due to increasing awareness about the importance of preventing rabies in pets and wildlife. The convenience of oral vaccines for wildlife and stray animals is driving demand, along with government initiatives to control rabies outbreaks. Consumers are willing to invest in oral vaccines to protect their pets and communities from this deadly disease.

Beijing Taitan Pharmaceutical Co., Ltd.
Shenzhen Kangtai Biological Products Co., Ltd.
Chengdu Institute of Biological Products Co., Ltd.
Changchun Zhuoyi Biological Co., Ltd
Tianjin Ringpu Bio-Technology Co., Ltd.
Changchun BCHT Biotechnology Co., Ltd.

Beijing Taitan Pharmaceutical Co., Ltd.

Establishment time : 2003

website : www.taitanpharma.com

Main Product : Pharmaceutical products

Company Profile

Beijing Taitan Pharmaceutical Co., Ltd. is a leading pharmaceutical company established in 2003. With a focus on research and development, the company offers a wide range of pharmaceutical products to both domestic and international markets. Known for its strong presence in the industry, Taitan Pharma continues to innovate and provide high-quality healthcare solutions.

Shenzhen Kangtai Biological Products Co., Ltd.

Establishment time : 1992

website : www.kangtaibio.com

Main Product : Vaccines, blood products, and diagnostic reagents

Company Profile

Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and has since become a major player in the biopharmaceutical industry. With a focus on vaccines, blood products, and diagnostic reagents, the company has established a strong presence in both domestic and international markets. With a large workforce of over 3,000 employees, Kangtai is known for its commitment to quality and innovation, making it a competitive force in the industry.

Chengdu Institute of Biological Products Co., Ltd.

Establishment time : 1967

website : http://www.cdibp.com.cn

Main Product : Vaccines, blood products, diagnostic reagents

Company Profile

Chengdu Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. Founded in 1967, the company has grown to become a major player in the industry, serving both domestic and international markets with a wide range of high-quality products. With a large company size and a strong competitive position, Chengdu Institute of Biological Products Co., Ltd. continues to innovate and advance in the field of biopharmaceuticals.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Tianjin Ringpu Bio-Technology Co., Ltd.

Establishment time : Tianjin Ringpu Bio-Technology Co., Ltd. was founded in 2007.

website :

Main Product : With a medium-sized operation, Ringpu Bio-Technology serves markets in China, Southeast Asia, and the Middle East.

Company Profile

Overall, Tianjin Ringpu Bio-Technology Co., Ltd. is a reputable player in the bio-technology sector, known for its quality products and market presence.

Changchun BCHT Biotechnology Co., Ltd.

Establishment time : Changchun BCHT Biotechnology Co., Ltd. was founded in 2007.

website :

Main Product : With a medium-sized team, BCHT has established itself as a leading provider in the field.

Company Profile

Changchun BCHT Biotechnology Co., Ltd. continues to grow and expand its presence in the global market.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326